| Senior Expert, Science & Technology - Potency |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
zář 18, 2024 |
| Executive Director, Global Operational Excellence |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
zář 18, 2024 |
| Senior Principal Statistical Programmer - Advanced Quantitative Sciences |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
zář 19, 2024 |
| Associate Director, Statistical Programming |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
zář 19, 2024 |
| Clinical Development Medical Director - Renal **80-100% |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
zář 20, 2024 |
| Global Program Clinical Head - CRM |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
zář 20, 2024 |
| SSO Study Start-Up Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
říj 16, 2024 |
| Director, Development Unit Management |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
říj 16, 2024 |
| GCP Inspection Project Manager |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Quality |
říj 16, 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
říj 16, 2024 |
| RA Operational Excellence Junior Associate – MEA |
Dubai |
Utd.Arab Emir. |
Development |
Innovative Medicines |
Research & Development |
říj 16, 2024 |
| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Vendor Alliance Lead Associate Director |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
United Kingdom |
Development |
Sandoz |
Research & Development |
říj 17, 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Senior Clinical Research Associate (Remote) |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
říj 17, 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
čvc 18, 2024 |
| Study Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
zář 05, 2024 |
| Head Regulatory Writing |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
říj 07, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
říj 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
říj 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
říj 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
říj 09, 2024 |
| Expert Science & Technology |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
zář 03, 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
zář 01, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
říj 09, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
srp 22, 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
čvc 18, 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
říj 14, 2024 |
| Risk & Assurance Manager |
Mumbai (Head Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
říj 16, 2024 |
| Country ERC Head, India |
Mumbai (Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
říj 16, 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
srp 29, 2024 |
| Manager- Data Privacy Review and Remediation |
Telangana |
India |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
říj 10, 2024 |
| Associate Director, Data Privacy, Digital & AI |
East Hanover |
USA |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
zář 04, 2024 |
| Associate Director - Risk & Assurance, EUROPE |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
říj 11, 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
říj 14, 2024 |
| ERP Assurance Senior Consultant-2 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
srp 20, 2024 |
| Business Planning and Analysis Manager, Novartis Technical Operations |
INSURGENTES |
Mexico |
Finance |
Innovative Medicines |
Audit & Finance |
srp 22, 2024 |
| Investor Relations Executive Director |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
srp 28, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
čvc 28, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
srp 05, 2024 |
| Financial Control & Compliance (FC&C) Lead |
Amiria |
Egypt |
Finance |
CTS |
Audit & Finance |
kvě 23, 2024 |
| Corporate Tax Manager |
Amiria |
Egypt |
Finance |
Corporate |
Audit & Finance |
kvě 31, 2024 |
| P2P & T&E Specialist (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
čvn 05, 2024 |
| P2P & T&E Business Partner (Japanese speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
čvn 12, 2024 |
| R2R Senior Specialist GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
čvn 13, 2024 |
| Global Digital FRA Automation Lead |
Hyderabad (Office) |
India |
Finance |
Corporate |
Audit & Finance |
čvn 20, 2024 |
| FP&A Manager |
İstanbul Kavacık |
Turkey |
Finance |
Innovative Medicines |
Audit & Finance |
čvn 28, 2024 |